india

Africa: The Launchpad for Indian Pharma

Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years,…

Meeting US FDA Standards Across the Board in India

In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…

Quality Compliance in Indian Pharma: The Learning Curve

One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…

Indian Contract Research Industry Set for Rapid Growth

The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is…

People to Watch in india

Thomas Broeer, managing director UK and Ireland for Aurobindo, has been at the helm of Aurobindo’s UK subsidiary, Milpharm Limited for almost two years and here discusses the UK market’s strengths, the potential impact of Brexit on the pharmaceutical industry and the pricing structures in place in the UK. The UK was the first European affiliate to be…

Indian Biosimilars: Going Global

Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven…

India: Still a Land of Opportunity for MNCs

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India…

MNCs’ Healthcare Access Initiatives in India

With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to…

Indian Pharma Manufacturing: Serving the World

Indian pharma production is growing rapidly – boosted by the Modi government’s ‘Make in India’ campaign…

Gender Diversity in Indian Pharma

India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the…

Colombia: The Great Indian Investment Wave

With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to…

India: Creating An Innovative Healthcare Ecosystem

At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based…

India: An Emerging Knowledge Superpower

“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we…

India: Good Endings, Good Beginnings

What probably best explains the contrasts in the Indian pharmaceutical landscape is the fact that India can take…